Related Experiment Video
Updated: Jun 27, 2026

Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration
Published on: April 27, 2018
Recurrent gene fusions in prostate cancer
Chandan Kumar-Sinha1, Scott A Tomlins, Arul M Chinnaiyan
1Michigan Center for Translational Pathology, University of Michigan Medical School, 1400 East Medical Center Drive, 5316 CCGC, Ann Arbor, Michigan 48109-0602, USA.
Recurrent gene fusions are common in prostate cancer, driven by androgen-controlled elements fused to Ets transcription factors. This discovery may redefine prostate cancer classification and treatment strategies.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Gene fusions and chromosomal rearrangements were historically associated with hematological malignancies and sarcomas.
- Their discovery in common epithelial tumors, like prostate cancer, challenges previous understandings of oncogenesis.
Purpose of the Study:
- To investigate the role and implications of recurrent gene fusions in prostate cancer.
- To explore the potential of these fusions in classifying and treating prostate cancer.
Main Methods:
- Analysis of gene fusions and chromosomal rearrangements in prostate cancer samples.
- Identification of specific gene fusion partners and regulatory elements.
Main Results:
- Recurrent gene fusions identified in a majority of prostate cancers.
- Prostate cancer gene fusions involve 5' regulatory elements, often androgen-controlled, fused to Ets transcription factors.
- This leads to overexpression of oncogenic transcription factors.
Conclusions:
- Ets gene fusions represent a distinct class of prostate cancer.
- These findings have significant implications for prostate cancer diagnosis, prognosis, and targeted therapy development.
Related Concept Videos
Cancers Originate from Somatic Mutations in a Single Cell
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

